Subcommittee Hearing Biosimilar Implementation: A Progress Report from FDA

Subcommittee on Primary Health and Retirement Security Date: Thursday, September 17, 2015 Time: 10:00 AM Location: 430 Dirksen Senate Office Building

Open in New Window

Witnesses

Panel I

  1. Janet Woodcock, M.D.
    Director
    Center for Drug Evaluation and Research, Food and Drug Administration
    Silver Spring, MD

Transcripts

Related Photos

Those in need of accommodations, including closed captioning for webcast hearings, should contact the Committee at 202-224-5375 or accessibility@help.senate.gov. So as to best enable staff to make arrangements, please call or email at least 3 business days in advance of the hearing.